- |||||||||| metformin / generics
Journal: Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation. (Pubmed Central) - Apr 7, 2019 ...3-Carboxyl proxyl nitroxide (Mito-CP) and Mito-Metformin, two mitochondria-targeted compounds, depleted intracellular ATP levels and persistently inhibited ATP-linked oxygen consumption in both KRAS WT and KRAS variant-containing colon cancer cells and had only limited effects on nontransformed intestinal epithelial cells...This is the first demonstration that drugs selectively targeting mitochondria induce mitophagy in cancer cells. Targeting bioenergetic metabolism with mitochondria-targeted drugs to stimulate mitophagy provides an attractive approach for therapeutic intervention in KRAS wild-type and overactive mutant expressing colon cancer.
- |||||||||| Journal: ATP-competitive DNA gyrase and topoisomerase IV inhibitors as antibacterial agents. (Pubmed Central) - Apr 5, 2019
Other common issues, such as low solubility, high protein binding, development of off-target resistance (e.g., via bacterial efflux pumps), are related to the structures of the inhibitors themselves, which is thus a main focus of design strategies. With some now in early clinical development, there is reasonable expectation that novel ATP-competitive inhibitors of GyrB/ParE(GrlB) will reach the market in the near future.
- |||||||||| doxorubicin hydrochloride / generics
Journal: The P-glycoprotein inhibitor diltiazem-like 8-(4-chlorophenyl)-5-methyl-8-[(2Z)-pent-2-en-1-yloxy]-8H-[1,2,4]oxadiazolo[3,4-c][1,4]thiazin-3-one inhibits esterase activity and H3 histone acetylation. (Pubmed Central) - Mar 28, 2019 ...The compound 8-(4-chlorophenyl)-5-methyl-8-[(2Z)-pent-2-en-1-yloxy]-8H-[1,2,4]oxadiazolo[3,4-c][1,4]thiazin-3-one namely 2c, is structurally related to the myocardial-calcium-channel-modulator diltiazem and is considered one of the most efficient P-glycoprotein inhibitors, able to induce apoptosis at low concentrations of doxorubicin in multidrug resistant ovarian cells...2c also inhibits cell esterase activity, acetylcholine esterase activity in vitro and cell histone H3 acetylation according to its structural homology with some known HAT inhibitors. The results obtained provide new knowledge on the biological activities of 2c and represent useful information when it is used as an inhibitor of drug resistance.
- |||||||||| Nexletol (bempedoic acid) / Esperion Therap, Otsuka
Clinical, Journal: Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol. (Pubmed Central) - Mar 27, 2019 P3 In this 52-week trial, bempedoic acid added to maximally tolerated statin therapy did not lead to a higher incidence of overall adverse events than placebo and led to significantly lower LDL cholesterol levels. (Funded by Esperion Therapeutics; CLEAR Harmony ClinicalTrials.gov number, NCT02666664.).
|